Science Explorer Interactive view Map

Silymarin and Mushroom Poisoning

Silymarin and Mushroom Poisoning is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 6.6k research works in it since 1950. 19.6% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the use of silymarin, a flavonolignan complex derived from milk thistle, in the treatment of liver diseases, including hepatitis and hepatocellular carcinoma. It explores silymarin's hepatoprotective and antioxidant effects, its potential as a supportive treatment in liver diseases, its role in cancer treatment and chemoprevention, as well as its pharmacokinetics and toxicity.

  • Silymarin
  • Liver Diseases
  • Hepatoprotective
  • Antioxidant
  • Cancer Treatment
  • Pharmacokinetics
  • Milk Thistle
  • Hepatitis C
  • Chemoprevention
  • Toxicity
Research works
6.6k
fractional, since 1950
In the world top 10%
1.3k
per year above
Top-10% rate
19.6%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+22%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Silymarin and Mushroom Poisoning research?

By volume, China and India publish the most (317 and 186 works in 2022–2025).

By volume, 2022–2025

  1. 1 China 317 works
  2. 2 India 186 works
  3. 3 Iran 121 works
  4. 4 United States 97 works
  5. 5 Türkiye 64 works
  6. 6 Egypt 64 works
  7. 7 South Korea 47 works
  8. 8 Italy 35 works
  9. 9 Japan 30 works
  10. 10 Saudi Arabia 29 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 32.0%India: 18.8%Iran: 12.2%United States: 9.8%6 others listed: 27.1%32%largest
China317 · 32.0%India186 · 18.8%Iran121 · 12.2%United States97 · 9.8%6 others listed268 · 27.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Silymarin and Mushroom Poisoning research?

By volume in 2022–2025, Mashhad University of Medical Sciences publishes the most Silymarin and Mushroom Poisoning research, followed by Tabriz University of Medical Sciences and King Saud University.

Who are the leading researchers in Silymarin and Mushroom Poisoning?

The most-cited researchers publishing on Silymarin and Mushroom Poisoning include Félix Carvalho.

  1. 1 Félix Carvalho Portugal 4.6k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Silymarin and Mushroom Poisoning research done?

The largest centres of Silymarin and Mushroom Poisoning research in 2022–2025 are Beijing (China), Tehran (Iran), Guangzhou (China) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Tehran.

Largest cities, 2022–2025

  1. 1 Beijing China 40 works
  2. 2 Tehran Iran 37 works
  3. 3 Guangzhou China 19 works
  4. 4 Shanghai China 18 works
  5. 5 Cairo Egypt 16 works
  6. 6 Kunming China 15 works
  7. 7 Chengdu China 13 works
  8. 8 Seoul South Korea 13 works
  9. 9 New Delhi India 13 works
  10. 10 Nanjing China 13 works

Where it is the local speciality

  1. TehranIR · 36.7 works4.8×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Silymarin and Mushroom Poisoning than the world average.

See Silymarin and Mushroom Poisoning on the map

Where is the best place to study Silymarin and Mushroom Poisoning?

Among universities, judged by research, Mashhad University of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Mashhad University of Medical SciencesIran 0.038.7%26.3×9 +193.8%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Silymarin and Mushroom Poisoning research growing?

Output in 2018–2022 was 22% higher than in 2013–2017, peaking in 2026. The fastest-growing topics are Silymarin and Mushroom Poisoning.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.